SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

of the SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 14, 2014

 

 

ATRICURE, INC.

(Exact name of registrant as specified in charter)

 

 

 

Delaware   000-51470   34-1940305

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

6217 Centre Park Drive

West Chester, OH

  45069
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (513) 755-4100

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

The stockholders of AtriCure, Inc. (the “Company”) voted on four items at the Annual Meeting of Stockholders held on May 14, 2014:

 

  1. The election of nine directors to serve one-year terms expiring at the 2015 Annual Meeting and until their successors have been duly elected and qualified;

 

  2. A proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2014;

 

  3. An advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement; and

 

  4. A proposal to approve the AtriCure, Inc. 2014 Stock Incentive Plan.

The nominees for director were elected based upon the following votes:

 

Director Nominees

   Votes For      Votes Withheld      Broker Non-Votes  

Michael H. Carrel

     18,038,449         791,110         3,920,552   

Mark A. Collar

     18,037,900         791,659         3,920,552   

Scott W. Drake

     18,066,183         763,376         3,920,552   

Michael D. Hooven

     18,038,299         791,260         3,920,552   

Richard M. Johnston

     17,313,744         1,515,815         3,920,552   

Elizabeth D. Krell, Ph.D.

     18,037,550         792,009         3,920,552   

Mark R. Lanning, C.P.A.

     18,037,900         791,659         3,920,552   

Karen P. Robards

     17,913,350         916,209         3,920,552   

Robert S. White

     18,145,925         683,634         3,920,552   

The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2014 received the following votes:

 

For:

     22,425,798   

Against:

     321,023   

Abstain:

     3,290   

Broker Non-Votes:

     0   

The advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement received the following votes:

 

For:

     17,179,749   

Against:

     1,605,669   

Abstain:

     44,141   

Broker Non-Votes:

     3,920,552   

The proposal to approve the AtriCure, Inc. 2014 Stock Incentive Plan received the following votes:

 

For:

     10,652,711   

Against:

     8,129,007   

Abstain:

     47,841   

Broker Non-Votes:

     3,920,552   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    ATRICURE, INC.
Date: May 15, 2014     By:  

/s/ M. Andrew Wade

      M. Andrew Wade
      Vice President and Chief Financial Officer